Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Jeffrey Alan Klein (6 out of 36 patents)

Paytra Alan Klein (4 out of 7 patents)

Bram Alan Klein (1 out of 2 patents)

6 patents: Sort by Forward Citations

1. 11723859 - Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity (2023-08-15),

2. 11696890 - Tumescent infiltration drug delivery of high subcutaneous drug concentrations with prolonged local and systemic effects and minimal local or systemic toxicity (2023-07-11),

3. 11241412 - Tumescent infiltration drug delivery of cannabinoids (2022-02-08),

4. 11213481 - Tumescent drug delivery (2022-01-04),

5. 10786483 - Tumescent contravenom drug delivery (2020-09-29),

6. 10322083 - Tumescent drug delivery (2019-06-18),

Company Overview

HK Pharma is a leading pharmaceutical company that specializes in the development and manufacturing of high-quality generic and branded pharmaceutical products. With state-of-the-art facilities and a team of experienced professionals, we are dedicated to improving patient outcomes and providing innovative healthcare solutions. Our diverse product portfolio includes medications for various therapeutic areas, including cardiovascular, respiratory, and oncology. HK Pharma is committed to delivering affordable and accessible healthcare products to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#41 in San Clemente, CA

#10,578 in California

#45,007 in US

San Clemente, CA, United States of America

Hk Pharma

Forward Citations = 6

3 inventors:

Jeffrey Alan Klein (6 out of 36 patents)

Paytra Alan Klein (4 out of 7 patents)

Bram Alan Klein (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hk Pharma. Retrieved from https://idiyas.com/company/hk-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]